thromboxanes has been researched along with Recrudescence in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bugert, P; Schedel, A; Weiskirchen, R; Yagmur, E | 1 |
FitzGerald, GA; Friesinger, GC; Maas, RL; Oates, JA; Roberts, LJ; Robertson, D; Robertson, RM | 1 |
Castaldi, PA | 1 |
Beisiegel, B; Darius, H; Erbel, R; Hafner, G; Meyer, J; Pop, T; Rupprecht, HJ; Treese, N | 1 |
Bass, TA; Bove, AA; Cowley, M; Goldberg, S; Macdonald, RG; Margolis, JR; Savage, MP; Taussig, AS; Vetrovec, G; Whitworth, HB | 1 |
4 trial(s) available for thromboxanes and Recrudescence
Article | Year |
---|---|
Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Arteries; Aspirin; Clinical Trials as Topic; Coronary Circulation; Coronary Vessels; Double-Blind Method; Female; Humans; Indomethacin; Ischemia; Male; Middle Aged; Recurrence; Thromboxane A2; Thromboxane B2; Thromboxanes; Time Factors; Veins | 1981 |
Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Collagen; Coronary Disease; Dipyridamole; Evaluation Studies as Topic; Humans; Myocardial Infarction; Platelet Aggregation; Prostaglandins; Recurrence; Sulfinpyrazone; Thromboxanes | 1981 |
[Modification of thrombocyte function in diagnostic and therapeutic interventions in cardiology].
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Fibrinolysis; Follow-Up Studies; Humans; Molsidomine; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Recurrence; Thromboxanes; Tissue Plasminogen Activator | 1991 |
Multi-Hospital Eastern Atlantic Restenosis Trial. II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Double-Blind Method; Follow-Up Studies; Humans; Mid-Atlantic Region; Placebos; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Prostaglandin; Receptors, Thromboxane; Recurrence; Sulfonamides; Thromboxanes | 1991 |
1 other study(ies) available for thromboxanes and Recrudescence
Article | Year |
---|---|
PTGS1 compound heterozygosity impairs gene expression and platelet aggregation and is associated with severe bleeding complications.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Arachidonic Acid; Blood Platelets; Cells, Cultured; Cyclooxygenase 1; Genetic Association Studies; Hemorrhage; Heterozygote; Humans; Male; Platelet Aggregation; Platelet Function Tests; Polymorphism, Single Nucleotide; Postoperative Complications; Recurrence; Thromboxanes; Transcriptome | 2013 |